Sign in

CIK 0001768224

  • Accelerated filer
  • Smaller reporting company

Arcturus Therapeutics Holdings Inc.

Sign in to watch
Ticker
ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 858-900-2660
Business address
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-05 HOLMES EDWARD W Director Grant or award · Stock option (right to buy) +15,000 15,000
2025-06-09 HOLMES EDWARD W Director Grant or award · Stock option (right to buy) +15,000 15,000
2024-06-14 HOLMES EDWARD W Director Exercise or conversion +3,131 3,131
2024-06-14 HOLMES EDWARD W Director Exercise or conversion · Deferred Stock Units −3,131 0
2024-06-14 HOLMES EDWARD W Director Grant or award · Stock option (right to buy) +15,000 15,000
2023-08-01 HOLMES EDWARD W Director Grant or award · Stock Option (right to buy) +11,869 11,869
2023-08-01 HOLMES EDWARD W Director Grant or award · Deferred Stock Units +3,131 3,131
2022-06-23 HOLMES EDWARD W Director Grant or award · Stock Option (right to buy) +15,000 15,000
2021-06-18 HOLMES EDWARD W Director Grant or award · Stock Option (right to buy) +15,000 15,000
2020-06-22 HOLMES EDWARD W Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-10-25 HOLMES EDWARD W Director Grant or award · Stock Option (right to buy) +15,000 15,000
2019-10-25 HOLMES EDWARD W Director Grant or award · Stock Option (right to buy) +20,000 20,000

Page 1 of 1 · 12 trades